Osieka R - Search Results

1

Phase I study of recombinant human tumor necrosis factor alpha in advanced malignant disease.

Moritz T, Niederle N, Baumann J, May D, Kurschel E, Osieka R, Kempeni J, Schlick E, Schmidt CG. Moritz T, et al. Among authors: osieka r. Cancer Immunol Immunother. 1989;29(2):144-50. doi: 10.1007/BF00199290. Cancer Immunol Immunother. 1989. PMID: 2720707 Free PMC article.

2

Response of human colon carcinoma xenografts to recombinant human tumor necrosis factor (TNF).

Osieka R, Glatte P, Niederle N, Schmidt CG. Osieka R, et al. Strahlenther Onkol. 1989 Jul;165(7):552-4. Strahlenther Onkol. 1989. PMID: 2749495 No abstract available.

3

Clinical pharmacology of sodium butyrate in patients with acute leukemia.

Miller AA, Kurschel E, Osieka R, Schmidt CG. Miller AA, et al. Among authors: osieka r. Eur J Cancer Clin Oncol. 1987 Sep;23(9):1283-7. doi: 10.1016/0277-5379(87)90109-x. Eur J Cancer Clin Oncol. 1987. PMID: 3678322

4

Chemosensitization by chlorpromazine (CPZ) and caffeine (C) in human melanoma xenografts sensitive or resistant to methyl-CCNU (semustine).

Osieka R, Glatte P, Schmidt CG. Osieka R, et al. Strahlenther Onkol. 1989 Jul;165(7):526-8. Strahlenther Onkol. 1989. PMID: 2749491 No abstract available.

5

Treatment of chronic myelogenous leukemia with recombinant interferon alfa-2b.

Niederle N, Kloke O, May D, Becher R, Osieka R, Schmidt CG. Niederle N, et al. Among authors: osieka r. Invest New Drugs. 1987;5 Suppl:S19-25. doi: 10.1007/BF00207259. Invest New Drugs. 1987. PMID: 3474219

6

Interferon alfa-2b in the treatment of chronic myelogenous leukemia.

Niederle N, Kloke O, Osieka R, Wandl U, Opalka B, Schmidt CG. Niederle N, et al. Among authors: osieka r. Semin Oncol. 1987 Jun;14(2 Suppl 2):29-35. Semin Oncol. 1987. PMID: 3473689

7

The combined modality approach in the treatment of inoperable small-cell anaplastic carcinoma of the lung.

Osieka R, Schmidt CG, Makoski HB, Scherer E. Osieka R, et al. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1977 May 20;89(1):9-18. doi: 10.1007/BF02571684. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1977. PMID: 195411 Clinical Trial.

8

Combined modality approach in small cell carcinoma of the bronchus. A pilot study.

Scherer E, Mamoski HB, Schmidt CG, Osieka R. Scherer E, et al. Among authors: osieka r. Bull Cancer. 1976 Jul-Sep;63(3):387-92. Bull Cancer. 1976. PMID: 1000091

9

Tumor biology and oncology.

Osieka R, Schmidt CG. Osieka R, et al. Thorac Cardiovasc Surg. 1986 Nov;34 Spec No 2:110-4. doi: 10.1055/s-2007-1022186. Thorac Cardiovasc Surg. 1986. PMID: 2432681 Review.

10

Sequential combination chemotherapy (CABOPP/VIM) for the treatment of high-grade malignant non-Hodgkin lymphoma.

Nowrousian MR, Meier CR, Schoetensack B, Anders C, Höffken K, Osieka R, Schmidt CG. Nowrousian MR, et al. Among authors: osieka r. Acta Oncol. 1989;28(4):495-500. doi: 10.3109/02841868909092257. Acta Oncol. 1989. PMID: 2477048

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters